Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review

Nicolas Salloum^#^{1

2}, Margot Chouchana^#^{3

4

5

6}, Romain Icick^{1

2

5

6}, Vanessa Bloch^{3

4

5

6}, Stéphanie Daumas^{6

7}, Salah El Mestikawy^{6

7

8}, Florence Vorspan^{1

2

5

6}, Virgile Clergue-Duval^{9

10

11

12}

Affiliations

¹ Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France.
² UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France.
³ Service de Pharmacie Hospitalière, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint- Denis, Paris, 75010, France.
⁴ UFR de Pharmacie, Université Paris Cité, 85 boulevard Saint-Germain, Paris, 75006, France.
⁵ UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.
⁶ FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.
⁷ Neuroscience Paris Seine, Institut de Biologie Paris Seine (NPS- IBPS), INSERM, CNRS, Sorbonne Université, 9 quai Saint Bernard, Paris, 75005, France.
⁸ Départment of Psychiatry, Douglas Research Center, McGill University, 6875 Boulevard Lasalle, Montréal, QC, H4H 1R3, Canada.
⁹ Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France. virgile.clergue-duval@aphp.fr.
¹⁰ UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France. virgile.clergue-duval@aphp.fr.
¹¹ UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.
¹² FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.

^# Contributed equally.

PMID: 39432105
DOI: 10.1007/s00213-024-06696-5

Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review

Nicolas Salloum et al. Psychopharmacology (Berl). 2024 Nov.

. 2024 Nov;241(11):2205-2222.

doi: 10.1007/s00213-024-06696-5. Epub 2024 Oct 21.

Authors

Affiliations

¹ Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France.
² UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France.
³ Service de Pharmacie Hospitalière, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint- Denis, Paris, 75010, France.
⁴ UFR de Pharmacie, Université Paris Cité, 85 boulevard Saint-Germain, Paris, 75006, France.
⁵ UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.
⁶ FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.
⁷ Neuroscience Paris Seine, Institut de Biologie Paris Seine (NPS- IBPS), INSERM, CNRS, Sorbonne Université, 9 quai Saint Bernard, Paris, 75005, France.
⁸ Départment of Psychiatry, Douglas Research Center, McGill University, 6875 Boulevard Lasalle, Montréal, QC, H4H 1R3, Canada.
⁹ Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France. virgile.clergue-duval@aphp.fr.
¹⁰ UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France. virgile.clergue-duval@aphp.fr.
¹¹ UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.
¹² FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.

^# Contributed equally.

PMID: 39432105
DOI: 10.1007/s00213-024-06696-5

Abstract

Rationale: No drugs are currently validated to treat psychostimulant use disorder (PUD). Pathophysiological studies consistently highlight the contribution of cholinergic mechanisms in psychostimulant use, including the vulnerability to PUD, paving the way for potential therapeutic strategies.

Objectives: The aim of this systematic review is to describe and discuss the efficacy of cholinergic agents in drug trials for patients with PUD.

Methods: A systematic review was conducted on April 4, 2024 in MedLine, Embase and Cochrane Library databases on controlled clinical drug trial of cholinergic agents in humans with PUD, psychostimulant abuse or dependence and psychostimulant use in recent year.

Results: Twenty-eight articles were included, twenty-one on cocaine and seven on amphetamines. Cholinergic agents used in these studies were biperiden (a muscarinic antagonist), mecamylamine (a nicotinic antagonist), nicotinic agonists, acetylcholinesterase inhibitors (AChEI), or citicoline. Two types of trials were identified. There were seventeen randomized controlled clinical trials evaluating cholinergic agents on psychostimulant use reduction in outpatients seeking treatment. Additionally, we retrieved eleven short-term «proof-of-concept» laboratory trials mainly with supervised psychostimulant administration and/or triggered craving challenges. Outpatient trials were heterogeneous and for most, inconclusive. Only two studies on galantamine (AChEI) and citicoline, reported a significant reduction of cocaine consumption. «Proof-of-concept» laboratory trials showed no evidence of efficacy on the selected outcomes, notably on craving.

Conclusions: This review does not support the current prescription of cholinergic agents to treat PUD. Replication clinical trials notably on galantamine or other AChEI, and proof-of-concept trials on comedown symptoms will be necessary to identify a potential therapeutic indication for cholinergic agents in PUD.

Keywords: Acetylcholine; Amphetamines; Cholinergic agents; Cocaine; Psychostimulant use disorder; Psychostimulants.

PubMed Disclaimer

References

1. Andersen MB, Werge T, Fink-Jensen A (2007) The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. J Pharmacol Exp Ther 321:1179–1182. https://doi.org/10.1124/jpet.107.119677 - DOI - PubMed
1. Antoine J, Berndt N, Astudillo M et al (2021) Cocaine treatment demands in 10 western European countries: observed trends between 2011 and 2018. Addiction 116:1131–1143. https://doi.org/10.1111/add.15237 - DOI - PubMed
1. Barazangi N, Role LW (2001) Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. J Neurophysiol 86:463–474. https://doi.org/10.1152/jn.2001.86.1.463 - DOI - PubMed
1. Bentzley BS, Han SS, Neuner S et al (2021) Comparison of treatments for Cocaine Use Disorder among adults: a systematic review and Meta-analysis. JAMA Netw Open 4:e218049. https://doi.org/10.1001/jamanetworkopen.2021.8049 - DOI - PubMed - PMC
1. Berlanga ML, Olsen CM, Chen V et al (2003) Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120:1149–1156. https://doi.org/10.1016/s0306-4522(03)00378-6 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

Fédération Hospitalo-Universitaire Network of Research in Substance Use Disorders, Assistance Publique Hopitaux de Paris and Université Paris Cité, Paris, France/Fédération Hospitalo-Universitaire Network of Research in Substance Use Disorders, Assistance Publique Hopitaux de Paris and Université Paris Cité, Paris, France

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review

Affiliations

Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous